Assessing risk for kidney stones using parathyroid hormone...

Details Assessing risk for kidney stones using parathyroid hormone... Assessing risk for kidney stones using parathyroid hormone...

2005-06-03

2009-06-02

Hobbs, Lisa J (Department: 1657)

Chemistry: molecular biology and microbiology

Measuring or testing process involving enzymes or...

C436S086000, C424S009100, C514S012200

Reexamination Certificate

active

07541140

ABSTRACT:
The present invention relates to identifying the risk of a subject developing renal stones utilizing an assessment of PTH agonist, antagonist and/or total PTH levels, optionally together with an assessment of serum and/or urine calcium levels and/or other analytes. The present description further relates to monitoring and guiding treatment for renal stones and kits useful therefore.

REFERENCES:
patent: 4086196 (1978-04-01), Tregear
patent: 4656250 (1987-04-01), Morita et al.
patent: 4968669 (1990-11-01), Rosenblatt et al.
patent: 5093233 (1992-03-01), Rosenblatt et al.
patent: 5208041 (1993-05-01), Sindrey
patent: 5317010 (1994-05-01), Pang et al.
patent: 5382658 (1995-01-01), Kronis et al.
patent: 5434246 (1995-07-01), Fukuda et al.
patent: 5496801 (1996-03-01), Holthuis et al.
patent: 5589452 (1996-12-01), Krstenansky et al.
patent: 5695955 (1997-12-01), Krstenansky et al.
patent: 5723577 (1998-03-01), Dong
patent: 5747456 (1998-05-01), Chorev et al.
patent: 5783558 (1998-07-01), Duvos et al.
patent: 5798225 (1998-08-01), Krstenansky et al.
patent: 5807823 (1998-09-01), Krstenansky et al.
patent: 5840831 (1998-11-01), Hamachi et al.
patent: 5849695 (1998-12-01), Cohen et al.
patent: 6689566 (2004-02-01), Cantor et al.
patent: 6743590 (2004-06-01), Cantor et al.
patent: 6838264 (2005-01-01), Zahradnik et al.
patent: 2002/0110871 (2002-08-01), Zahradnik et al.
patent: 2005/0170443 (2005-08-01), Cantor
Williams CP, Child DF, Hudson PR, De Soysa L, Davies GK, Davies MG, De Bolla AR. (1996) Inappropriate phosphate excretion in idiopathic hypercalciuria: the key to a common cause and future treatment? J Clin Pathol 49: pp. 881-888.
Lepage R, Roy L, BrossardJ-H, Rousseau L, Dorais C, Lazure C, and D'Amour P. (1998) A non-(1-84) circulating parathyroid hormone (PTH) fragment interferes significantly with intact PTH commercial assay measurements in uremic samples. Clin Chem 44: 805-809.
Peacock M (Nov. 2002) Primary hyperparathyroidism and the kidney: biochemical and clinical spectrum. J Bone Min Res, vol. 17, supplement 2, pp. N87-N94.
Bushinsky DA et al (2000) Calcium phosphate supersaturation regulates stone formation in genetic hypercalciuric stone-forming rats. Kidney Int, vol. 57, pp. 550-560.
Chau H et al (Apr. 2003) Renal calcification in mice homozygous for the disrupted Type IIa Na/Pi cotransporter gene Npt2. J Bone Min Res, vol. 18, No. 4, pp. 644-657.
Sneddon WB et al (published online Aug. 14, 2003) Activation-independent parathyroid hormone receptor internalization is regulated by NHERF1 (EBP50). J Biol Chem, vol. 278, No. 44, pp. 43787-43796.
Murer H et al (1999) Posttranslational regulation of the proximal tubule NaPi-II transporter in response to PTH and dietary Pi. Am J Physiol Renal Physiol, vol. 277, (Renal Physiol vol. 46,) pp. F676-F684.
Biochemistry, Stryer ed., 2nd ed. (1981) pp. 13-15.
Bringhurst et al., Hormones and Disorders of Mineral Metabolism, in Williams Textbook of Endocrinology, 10th ed., (2003) p. 1309.
Caetano et al., Equus Genome Res. (1999) 9(12):1239-1249.
Divieti et al., Endocrinology (2002) 143(1):171-176.
Friedman and Gesek, Physiol. Rev. (1995) 75:429-471.
Henikoff et al., PNAS (1992) 89:10915-10919.
Integration of Renal Mechanisms, in Medical Physiology, Guyton and Hall eds., 10th ed. (2000) p. 343.
Lei et al., J. Biol. Chem. (1995) 270(20):11882-11886.
Nguyen-Yamamoto et al., Endocrinology (2001) 142(4):1386-1392.
Nissenson et al., J. Biol. Chem. (1988) 263(26):12866-12871.
Slatopolsky et al., Kidney Int. (2000) 58:753-761.
Sneddon et al., J. Biol. Chem. (2003) 278(44):43787-43796.
Stewart et al., J. Clin. Invest. (1988) 81(2):596-600.
Stoller, Urinary Stone Disease, in Smith's General Urology, Tanagho and McAninch, eds., 16th ed. (2004) pp. 256-274.
Thompson et al., PNAS USA (1988) 85(15):5673-5677.
Watson et al., Molecular Biology of the Gene, Benjamin/Cummings Pub. Co., 4th ed. (1987) p. 224.
Yates et al., J. Clin. Invest. (1988) 81(3):932-938.

Affiliated with

Also associated with

Rating

Assessing risk for kidney stones using parathyroid hormone... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Assessing risk for kidney stones using parathyroid hormone..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Assessing risk for kidney stones using parathyroid hormone... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4144918